Are peptides legal in the European Union?
Sourced guide to the legal status of peptides in the European Union, refreshed automatically from live research.
Overall Status: Restricted
Short answer: Peptides are restricted, not freely legal, across the European Union: medically-approved peptides such as semaglutide, tirzepatide and somatropin (HGH) are prescription-only medicines authorised centrally by the European Medicines Agency, while unapproved 'research' peptides like BPC-157 and TB-500 have no EU marketing authorisation and cannot lawfully be sold or marketed for human use.
Important: This information is for educational purposes only and does not constitute legal advice. Laws and enforcement policies change. Consult a qualified attorney for specific legal guidance.
Overview
Peptides are restricted in the European Union rather than freely legal or outright banned as a class: some peptide drugs (semaglutide, tirzepatide, somatropin/HGH) are approved, prescription-only medicines regulated under EU pharmaceutical law, while non-approved research peptides such as BPC-157 and TB-500 fall outside the authorised medicines system and cannot legally be marketed, advertised, or sold as drugs or supplements in any Member State. The European Medicines Agency (EMA) centrally authorises many of these products under Regulation (EC) 726/2004, and national competent authorities in each Member State enforce prescription and pharmacy-only sales rules under Directive 2001/83/EC. Import of unauthorised peptides by mail order, or personal import without a valid prescription, generally violates national pharmacy and customs law even though enforcement intensity varies by country.
Key Points
- The European Medicines Agency authorises medicinal peptides such as semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro) for the EU market as prescription-only medicines under the EU centralised authorisation procedure. [5]
- EU medicinal products law, set out in Directive 2001/83/EC on the Community code relating to medicinal products for human use, requires that products intended to treat or prevent disease in humans hold a marketing authorisation and, for most peptide hormones, be dispensed only against a medical prescription. [2]
- Research-grade peptides such as BPC-157 and TB-500 have no marketing authorisation anywhere in the EU, so they cannot legally be advertised, labelled, or sold as medicines, food supplements, or cosmetic ingredients for human use under EU pharmaceutical law. [2]
- The Falsified Medicines Directive (2011/62/EU) restricts online sale of prescription-type medicines in the EU to authorised pharmacies and registered online sellers, which is the legal basis EU Member States use to act against unlicensed online 'research chemical' peptide vendors. [3]
- Somatropin (recombinant human growth hormone) is sold in the EU only as a prescription-only medicine for specific approved indications such as growth hormone deficiency, and its use outside those approved medical indications is not authorised. [2]
- A traveller can generally bring a personal supply of a legitimately prescribed peptide medicine into an EU country for personal medical treatment, but importing unapproved research peptides by mail order from outside the EU, or without a valid prescription for a prescription-only peptide, risks seizure by customs and possible legal consequences under national pharmacy law. (No reliable source found for this point -- flagged as unverified rather than stated as fact.)
- The World Anti-Doping Agency's Prohibited List, which EU national anti-doping organisations apply to competitive athletes, bans growth hormone releasing peptides and related growth factors under category S2, meaning athletes in EU countries who use such peptides risk sporting sanctions regardless of the substance's civil legal status. [4]
Peptide-by-peptide status in European Union
| BPC-157 | BPC-157 has no marketing authorisation as a medicine anywhere in the European Union, so it cannot be lawfully sold, labelled, or advertised for human consumption in any EU Member State, and it exists only in an unregulated 'research chemical' market. [2] |
|---|
| Semaglutide (Ozempic/Wegovy/Rybelsus) | Semaglutide is a legally approved, prescription-only medicine in the European Union, authorised by the European Medicines Agency for type 2 diabetes (Ozempic/Rybelsus) and weight management (Wegovy). [5] |
|---|
| Tirzepatide (Mounjaro) | Tirzepatide is a legally approved, prescription-only medicine in the European Union, centrally authorised via the EMA for type 2 diabetes and weight management under the brand name Mounjaro. [6] |
|---|
| TB-500 (Thymosin beta-4) | TB-500 has no EU marketing authorisation as a medicine, meaning it cannot be legally sold or marketed for human use in the European Union and remains an unregulated research compound. [2] |
|---|
| Human Growth Hormone (somatropin) | Somatropin (HGH) is a legal, prescription-only medicine in the European Union when prescribed for approved medical indications such as growth hormone deficiency, but non-prescribed use for bodybuilding or anti-ageing purposes is not an authorised use and such use is also banned in sport. [2] |
|---|
Last researched: 2026-09-10
Frequently asked questions
No: BPC-157 and similar research peptides have no EU marketing authorisation, so there is no lawful prescription-only or over-the-counter retail channel for them in any EU Member State, and products sold online as 'research chemicals' fall outside the authorised medicines system.
[2]
Personal import into the EU is generally only protected for legitimately prescribed medicines carried by the patient for their own treatment; mail-ordering unapproved research peptides from outside the EU, or prescription-only peptides without a valid prescription, is not a protected legal import route and can be intercepted by customs.
Yes, licensed doctors in EU Member States can prescribe EMA-approved semaglutide (Wegovy) or tirzepatide (Mounjaro) for weight management via telehealth consultations, subject to each Member State's own rules on remote prescribing and pharmacy dispensing.
[5]
Selling unauthorised peptides as medicines in an EU Member State can trigger enforcement under national medicines law implementing Directive 2001/83/EC and the Falsified Medicines Directive, which can include product seizure, sales bans, and potential criminal or administrative penalties depending on the Member State.
[3]
HGH (somatropin) is legal in the EU only as a prescription medicine for approved medical conditions like growth hormone deficiency; using it without a prescription for muscle-building or anti-ageing purposes is not an authorised use and is separately prohibited for competitive athletes under the WADA Prohibited List.
[4]